No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 0 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T17:52:51.118Z. Latest historical point 2026-10-05.
The latest delayed quote for Pantages Capital Acquisition Corp (PGAC) stock was $10.88 as of Oct 6, 2026, 12:45 PM EDT, up 0.93% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +5.0%
Pantages Capital Acquisition Corporation currently lacks significant operational activities. Its principal objective is to pursue and finalize a strategic business combination, which may take the form of a merger, a share exchange, an asset acquisition, a share purchase, a corporate reorganization, or a similar transaction with one or more entities.
Shell Companies · Wilmington, DE
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
N/A
vs Estimate
N/A
Revenue
$0.00
vs Estimate
N/A
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1PGAC | $119.96M | $10.88 | +0.93% | +5.04% | N/A | N/A | N/A |
| 2RVSB | $120.13M | $5.96 | -0.53% | +16.65% | -1.40% | +3.47% | vs PGAC |
| 3SPEG | $119.77M | $10.41 | +0.14% | +4.08% | N/A | N/A | vs PGAC |
| 4CEPS | $120.48M | $10.21 | -0.58% | N/A | N/A | N/A | vs PGAC |
| 5ALPX | $118.64M | $9.96 | -0.05% | N/A | N/A | N/A | vs PGAC |
| 6BRKH | $117.61M | $10.00 | -0.10% | N/A | N/A | N/A | vs PGAC |
Consensus Rating
No analyst recommendations available
Average Price Target
N/A
Low
N/A
Current
$10.88
High
N/A
